Zur Financial Statements From 2010 to 2025
| ZRSEF Stock | USD 10.24 0.00 0.00% |
Check Zur Rose financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zur Rose's main balance sheet or income statement drivers, such as , as well as many indicators such as . Zur financial statements analysis is a perfect complement when working with Zur Rose Valuation or Volatility modules.
Zur |
Zur Rose Group Company Shares Outstanding Analysis
Zur Rose's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Zur Rose Shares Outstanding | 13.49 M |
Most of Zur Rose's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zur Rose Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Zur Rose Group has 13.49 M of shares currently outstending. This is 92.53% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The shares outstanding for all United States stocks is 97.64% higher than that of the company.
Zur Rose Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zur Rose's current stock value. Our valuation model uses many indicators to compare Zur Rose value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zur Rose competition to find correlations between indicators driving Zur Rose's intrinsic value. More Info.Zur Rose Group is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zur Rose's earnings, one of the primary drivers of an investment's value.About Zur Rose Financial Statements
Zur Rose stakeholders use historical fundamental indicators, such as Zur Rose's revenue or net income, to determine how well the company is positioned to perform in the future. Although Zur Rose investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zur Rose's assets and liabilities are reflected in the revenues and expenses on Zur Rose's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zur Rose Group. Please read more on our technical analysis and fundamental analysis pages.
Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland. Zur Rose operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 2131 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Zur Pink Sheet
Zur Rose financial ratios help investors to determine whether Zur Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zur with respect to the benefits of owning Zur Rose security.